Histopathological and Immunophenotypic Features of Ipilimumab ‐Associated Colitis Compared to Ulcerative Colitis

ConclusionsIpi‐AC is a distinct pathologic entity with notable clinical and histopathological differences compared to UC. These findings provide insights into the pathophysiology of immune‐related adverse events (iAEs) from ipilimumab therapy.This article is protected by copyright. All rights reserved.

Source: Journal of Internal Medicine - February 21, 2018 Category: Internal Medicine Authors: Brittany L. Adler, Maryam K. Pezhouh, Amy Kim, Lan Luan, Qingfeng Zhu, Faiz Gani, Mark Yarchoan, Jonathan Chen, Lysandra Voltaggio, Alyssa Parian, Mark Lazarev, Gregory Y. Lauwers, Timothy M. Pawlik, Elizabeth A. Montgomery, Elizabeth Jaffee, Dung T. Le, Tags: Original Article Source Type: research